The role of rare ginsenosides in the prevention and treatment of liver diseases.
1/5 보강
[ETHNOPHARMACOLOGICAL RELEVANCE] Ginseng (Panax ginseng C.
APA
Zhang Y, Liu Y, et al. (2026). The role of rare ginsenosides in the prevention and treatment of liver diseases.. Journal of ethnopharmacology, 355(Pt B), 120666. https://doi.org/10.1016/j.jep.2025.120666
MLA
Zhang Y, et al.. "The role of rare ginsenosides in the prevention and treatment of liver diseases.." Journal of ethnopharmacology, vol. 355, no. Pt B, 2026, pp. 120666.
PMID
41038332
Abstract
[ETHNOPHARMACOLOGICAL RELEVANCE] Ginseng (Panax ginseng C. A. Mey.) is a traditional herb that occupies a very important position in traditional Chinese medicine (TCM). Many references have recorded the traditional application methods of ginseng, which improve the effects of liver-blood insufficiency and chronic liver injury. Modern studies have found that rare ginsenosides are the key to their role and have therapeutic effects on a variety of liver diseases, further verifying their traditional applications.
[AIM OF THIS REVIEW] This article reviews recent research advances on the structure, origin and pharmacological effects of rare ginsenosides to evaluate the preventive and therapeutic effects of rare ginsenosides on different types of liver diseases.
[MATERIALS AND METHODS] This article utilized keywords like "Rare ginsenosides", "Source", "Drug-induced liver injury", "Metabolic dysfunction-associated fatty liver disease", "Liver fibrosis", "Hepatocellular carcinoma", and "Therapeutic interventions" to gather research on rare ginsenosides related to liver diseases from databases such as PubMed, Web of Science, and CNKI, up to September 2025. The collected information was then summarized and analyzed.
[RESULTS] The structural characterization and preparation process of rare ginsenosides were clarified. In terms of pharmacological activities, rare ginsenosides possess a variety of activities, including anti-inflammatory, antioxidant, anti-tumor and immunomodulatory. In addition, rare ginsenosides showed protective effects against liver diseases through various mechanisms. However, their clinical application remains limited due to low content, poor water solubility, low oral bioavailability, and unclear mechanisms. Future efforts will accelerate translation through fermentation optimization, nanocarriers, structural modification, and microbiome research.
[CONCLUSION] The multiple pharmacological activities of rare ginsenosides make them candidates for the treatment of various liver diseases and provide a broader direction for exploring the Chinese medicine treatment of liver diseases.
[AIM OF THIS REVIEW] This article reviews recent research advances on the structure, origin and pharmacological effects of rare ginsenosides to evaluate the preventive and therapeutic effects of rare ginsenosides on different types of liver diseases.
[MATERIALS AND METHODS] This article utilized keywords like "Rare ginsenosides", "Source", "Drug-induced liver injury", "Metabolic dysfunction-associated fatty liver disease", "Liver fibrosis", "Hepatocellular carcinoma", and "Therapeutic interventions" to gather research on rare ginsenosides related to liver diseases from databases such as PubMed, Web of Science, and CNKI, up to September 2025. The collected information was then summarized and analyzed.
[RESULTS] The structural characterization and preparation process of rare ginsenosides were clarified. In terms of pharmacological activities, rare ginsenosides possess a variety of activities, including anti-inflammatory, antioxidant, anti-tumor and immunomodulatory. In addition, rare ginsenosides showed protective effects against liver diseases through various mechanisms. However, their clinical application remains limited due to low content, poor water solubility, low oral bioavailability, and unclear mechanisms. Future efforts will accelerate translation through fermentation optimization, nanocarriers, structural modification, and microbiome research.
[CONCLUSION] The multiple pharmacological activities of rare ginsenosides make them candidates for the treatment of various liver diseases and provide a broader direction for exploring the Chinese medicine treatment of liver diseases.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Comment on: "Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition".
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study.
- Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].
- Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.